Eden Research
EDEN · AIM · Chemicals · mcap £19m · 2.3p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 06 Oct 26 | Investor presentation
Eden BioSolutions plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, will provide an update to shareholders on the IMC platform, delivering the same presentation that was used at the Company |
+0.0% | |
| 29 Sep 26 | AGM Statement
Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, provides an update to shareholders ahead of its Annual General Meeting (‘AGM’) today at Cavendish's office, 1 Bartholomew Clo |
+0.0% | |
| 28 Sep 26 | US EPA approves expanded label for Mevalone
US EPA approves expanded label for Mevalone fungicide covering additional high-value crops and diseases. |
+4.8% | |
| 26 Aug 26 | Results | Final Results
Revenue £4.9m, operating loss £2.9m for 15 months to March 2026; raised £10.8m for product development. |
−6.4% |
| 04 Aug 26 | Regulatory approvals in Slovakia and Egypt
Mevalone fungicide receives regulatory approval in Slovakia and Egypt, expanding geographic reach. |
+0.0% | |
| 25 Jun 26 | 2026 Green Economy Mark
Eden Research confirmed in London Stock Exchange 2026 Green Economy Mark cohort of 95 companies. |
+0.0% | |
| 27 May 26 | Board change | Directorate Change
Derek McAllan stepped down as non-Executive Director due to ill health; Rob Cridland becomes interim Audit Committee chair. |
+0.0% |
| 28 Apr 26 | Trading update | Trading Update
Revenue c. £4.9m for 15 months to March 2026, in line with expectations; regulatory approvals and partnerships advancing. |
−8.3% |
| 10 Apr 26 | Fundraise | Completion of Conditional Placing and TVR
Conditional placing completed, raising £10.8m; 190m new shares to be admitted to AIM on 13 April. |
+18.2% |
| 08 Apr 26 | Fundraise | Satisfaction of Conditions of Conditional Placing
Conditions satisfied for conditional placing announced on 2 February 2026. |
−3.5% |
| 02 Apr 26 | Thymolflex EPA approval
Partner Véto-pharma receives EPA approval for Thymolflex, a thymol-based Varroa treatment for bees. |
−1.7% | |
| 05 Feb 26 | Fundraise | Result of Retail Offer
Retail offer closed raising £0.2m gross proceeds at 4.0p per share; total fundraising £10.8m conditional on shareholder approval. |
−3.7% |
| 02 Feb 26 | Fundraise | Launch of Retail Offer
Eden Research launches retail offer of up to £500,000 at 4.0 pence per share as part of £10.7m fundraising. |
+1.3% |
| 02 Feb 26 | Fundraise | Proposed Placing and Subscription
Eden Research raises £3.1m firm and £7.6m conditional placing at 4.0p per share, plus retail offer. |
+1.3% |
| 09 Jan 26 | Novellus+ Regulatory Authorisation in Chile
Eden receives first South American regulatory approval for Novellus+ fungicide in Chile for grapes. |
+18.0% | |
| 07 Jan 26 | Mevalone Label Extension in France
Mevalone approved in France for use on grapes against downy and powdery mildew. |
+14.8% | |
| 18 Dec 25 | Appointment of Syngenta as Distribution Partner
Eden appoints Syngenta as exclusive distribution partner for ornamental crops fungicide in EU and UK. |
+8.3% | |
| 20 Nov 25 | 3LOGY Label Extension in Italy
3LOGY approved in Italy for additional crops including legumes, avocado and vegetables, expanding addressable market by over 20,000 hectares. |
+2.3% | |
| 17 Nov 25 | Ecovelex 2025 Approval in Italy
Ecovelex granted temporary approval in Italy for maize seed treatment for 2026 growing season. |
+0.0% |
Company filings. Not investment advice.